These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 10932458

  • 21. The ineffectiveness of retrospective drug utilization review.
    Hennessy S, Strom BL.
    LDI Issue Brief; 2003 Sep; 9(1):1-4. PubMed ID: 14577443
    [Abstract] [Full Text] [Related]

  • 22. Michigan drug utilization review and OBRA 90.
    Sandusky M.
    Mich Med; 1993 Apr; 92(4):38-9. PubMed ID: 8231930
    [Abstract] [Full Text] [Related]

  • 23. Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial.
    Dormuth CR, Maclure M, Bassett K, Jauca C, Whiteside C, Wright JM.
    CMAJ; 2004 Oct 26; 171(9):1057-61. PubMed ID: 15505268
    [Abstract] [Full Text] [Related]

  • 24. Spillover effects of restrictive drug formularies in the statin class: a descriptive study of the Medicaid preferred drug list in Texas.
    Wang YR.
    Manag Care Interface; 2006 Nov 26; 19(11):32-4. PubMed ID: 17137239
    [Abstract] [Full Text] [Related]

  • 25. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents.
    Monane M, Glynn RJ, Avorn J.
    Clin Pharmacol Ther; 1996 Jan 26; 59(1):83-92. PubMed ID: 8549038
    [Abstract] [Full Text] [Related]

  • 26. The influence of co-morbidities on prescribing pharmacotherapy for insomnia: evidence from US national outpatient data 1995-2004.
    Pawaskar MD, Joish VN, Camacho FT, Rasu RS, Balkrishnan R.
    J Med Econ; 2008 Jan 26; 11(1):41-56. PubMed ID: 19450109
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May 26; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 30. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA, Carr RM.
    WMJ; 2006 Sep 26; 105(6):36-9. PubMed ID: 17042418
    [Abstract] [Full Text] [Related]

  • 31. National Ambulatory Medical Care Survey: 2001 summary.
    Cherry DK, Burt CW, Woodwell DA.
    Adv Data; 2003 Aug 11; (337):1-44. PubMed ID: 12924075
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of reducing antibiotic prescribing for acute bronchitis on patient satisfaction.
    Gonzales R, Steiner JF, Maselli J, Lum A, Barrett PH.
    Eff Clin Pract; 2001 Aug 11; 4(3):105-11. PubMed ID: 11434073
    [Abstract] [Full Text] [Related]

  • 40. Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.
    Cluxton RJ, Li Z, Heaton PC, Weiss SR, Zuckerman IH, Moomaw CJ, Hsu VD, Rodriguez EM.
    Pharmacoepidemiol Drug Saf; 2005 Jan 11; 14(1):1-9. PubMed ID: 15546159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.